Congrong Shujing Granules ameliorates mitochondrial associated membranes to against MPP+-induced neurological damage in the cellular model of Parkinson’s disease
The findings provide novel insights into the potential of CRSJG in treating neuronal loss in PD.
Authors
- Qian Xu (ORCID: https://orcid.org/0000-0002-5223-9967)
- Xinxin Yuan (ORCID: https://orcid.org/0000-0002-7303-3191)
- Peizhen Huang
- Jing Cai (ORCID: https://orcid.org/0000-0003-4128-572X)
- Ying Liu (ORCID: https://orcid.org/0000-0002-7292-3221)
- Ting Liu (ORCID: https://orcid.org/0000-0001-8504-0754)
- Dan Chen (ORCID: https://orcid.org/0000-0003-1289-1077)
- Mei Zhou
- Huiling Cheng (ORCID: https://orcid.org/0000-0002-2249-4860)
- Chutian Zhang (ORCID: https://orcid.org/0000-0001-5760-4997)
Institutions
- Fujian University of Traditional Chinese Medicine (CN)
- Hubei Provincial Hospital of Traditional Chinese Medicine (CN)
- Hubei University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-05-30
- DOI
- https://doi.org/10.3389/fphar.2025.1509317
- Citations
- 2
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.78
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Fujian Province